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The inflammatory response of the supraspinatus muscle in rotator cuff tear conditions. 1 
Running title: Muscle inflammation and rotator cuff 2 
 3 
Abstract 4 
Background: Rotator cuff (RC) disorders involve a spectrum of shoulder conditions from early 5 
tendinopathy to full-thickness tears leading to impaired shoulder function and pain. The pathology 6 
of RC disorder is, nonetheless, still largely unknow . It is our hypothesis that supraspinatus (SS) 7 
tendon tear leads to sustained inflammatory changes of the SS muscle along with fatty infiltration 8 
and muscle degeneration, which are threshold markers for poor RC muscle function. The aim of this 9 
study was to determine the extent of this muscle inf ammation in conjunction with  lipid 10 
accumulation and fibrosis in RC tear conditions. 11 
Methods:We used proteomics, histology, electrochemiluminescence immunoassay, and qPCR 12 
analyses to evaluate inflammatory and degenerative markers and fatty infiltration in biopsies from  13 
22 patients undergoing surgery with repair of a full- thickness supraspinatus (SS) tendon tear.  14 
Results: Bioinformatic analysis  showed that proteins involved in innate immunity, extracellular 15 
matrix organization, and lipid metabolism were among the most upregulated whereas mitochondrial 16 
electronic transport chain along with muscle fiber function were among the most downregulated. 17 
Histological analysis confirmed changes in muscle fib r organization and the presence of 18 
inflammation and fatty infiltration. Inflammation appeared to be driven by a high number of 19 
infiltrating macrophages, accompanied by elevated matrix metalloprotease levels and changes in 20 
transforming growth factor-β  and cytokine levels in the SS compared to the deltoi  muscle.  21 
Conclusions: We demonstrated massive SS muscle inflammation after tendon tear combined with 22 
fatty infiltration and degeneration. The regulation of tissue repair is thus extremely complex, and it 23 
may have opposite effects at different time points of healing. Inhibition or stimulation of muscle 24 
inflammation may be a potential target to enhance outcome of  the repaired torn RC.  25 
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Level of evidence: Basic Science Study; Histology, Molcular and Cell Biology 26 
Keywords:  Shoulder disorder, muscle damage, proteomics, protein changes, extracellular matrix 27 
degeneration, fatty infiltration 28 
 29 
Introduction 30 
Rotator cuff (RC) lesions are some of the most commn shoulder conditions in humans and can 31 
lead to weakness, pain, and limited/reduced mobility. The prevalence of RC tears is age-dependent, 32 
and both partial and full-thickness RC tears increase markedly after 50 years of age 48. The etiology 33 
of RC diseases is multifactorial with frequent involvement of  the supraspinatus (SS) tendon 5. Full-34 
thickness SS tears do not heal spontaneously, and surgically repaired  RC tears tend to heal poorly 35 
15; 33. A recent Cochrane review questioned whether repai of RC tears provides meaningful benefit 36 
to patients with symptomatic RC tears 24. There is, therefore, a pressing need to better understand 37 
the pathophysiology behind RC tear conditions in order to improve results after surgical repair of 38 
RC tendon tears. 39 
In full-thickness RC tears, increased numbers of immune cells have been demonstrated in the 40 
synovial tissue adjacent to the SS tendon 1 a d an increase in tear size correlated with a grete  pro-41 
inflammatory response in the synovium 6; 45. Recent data suggest that the RC muscles also become 42 
inflamed in the presence of an RC tear 14, and results from experimental models suggest that acute 43 
inflammation plays a detrimental role in the onset of chronic muscle damage following RC tears 16; 44 
29. It is also generally agreed that chronic RC tendon lesion leads to  degenerative muscle changes 45 
in the form of fatty infiltration and fibrosis 10. 46 
Several animal studies have provided evidence of significant increases in inflammatory cytokines, 47 
growth factors, and matrix metalloproteases (MMPs), indicating muscle inflammation following 48 
experimental RC tendon tear 16; 29. Changes in the biology of human RC muscles in tear conditions 49 
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remain poorly defined at the cellular level, however, and RC muscle as a target for inflammation 50 
following RC tear is only sparsely understood 14; 23. 51 
The aim of this study was to provide a more robust understanding of the inflammatory environment 52 
of human SS muscle in RC tear conditions. It is our hypothesis that inflammatory conditions 53 
precede disturbances of the muscle architecture, and eventually lead to RC muscle fatty infiltration 54 
and degeneration. To investigate this, we applied quantitative proteomics followed by histological, 55 
multiplex chemiluminescence, and qPCR analyses of inflammation in SS and deltoid muscle 56 
biopsies that were harvested from patients undergoing surgery for RC tears. 57 
 58 
Materials and methods 59 
Patient cohort 60 
Patients (n=22) with a relevant shoulder trauma and cli ical signs of an RC lesion were recruited 61 
(Supplementary Table 1). Median age of lesions was 3.3 months (IQR 2-14 months). Patients 62 
underwent preoperative magnetic resonance imaging scan revealing SS tendon tear, and all tears 63 
were confirmed at surgery. Informed written consent was obtained from all patients. The workflow 64 
of the project is presented in Figure 1. 65 
 66 
Human tissue 67 
The RC and musculotendinous junction of the SS muscle were gently débrided from fascia and 68 
bursal tissue using a blunt shaver. SS tendon and muscle biopsies were harvested from the edge of 69 
the tendon and approximately one centimeter medial to the tendon, respectively, under direct 70 
visualization from the arthroscope. Comparative biops es were taken from assumed healthy, 71 
ipsilateral deltoid muscles. Biopsies were snap-frozen on dry ice and stored at -80°C or fixed in 72 
10% neutral buffered formalin and embedded in paraffin. 73 
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 74 
Blood samples 75 
Blood samples were obtained in EDTA coated test tubes immediately prior to surgery to estimate 76 
preoperative peripheral inflammation. Hemoglobin, C-reactive protein and white blood cell counts 77 
were analyzed. The patient cohort was also tested for presence of rheumatic factors (anti-nuclear, 78 
anti-cyclic citrullinated, and mitochondrial antibodies and rheumafactor). 79 
 80 
Histology and Immunohistochemistry 81 
SS or deltoid muscle tissue was sectioned into 2μm thick sections on a microtome. 82 
Immunohistochemistry for CD68 was performed on the OMNIS platform (Dako/Agilent, Denmark) 83 
using mouse anti-CD68 (1:50, Clone PG-M1) antibody and EnVisionTM FLEX as detection system, 84 
while immunohistochemistry for FOXP3, CD3, and adipophilin was performed on a BenchMark 85 
Ultra immunostainer (Ventana Medical Systems, AZ, USA) using mouse anti-FOXP3 (1:40, clone 86 
236A/E7), rabbit anti-CD3 (“ready-to-use”, clone 2GV6), and mouse anti-adipophilin (1:50, clone 87 
AP125) antibodies and the OptiView-DAB detection system. Parallel sections were stained with 88 
hematoxylin and eosin (HE). 89 
Slides were scanned on a NanoZoomer 2.0 RS scanner (Hamamatsu Photonics, Visiopharm, 90 
Denmark). To produce merged images, NDP view (Hamamatsu Photonics, version 2.6.17)  was 91 
applied to find identical regions on neighboring cells stained for FOXP3 and CD3, respectively. 92 
The images were processed and merged using Photoshop C6 (Adobe Systems, CA, USA) and 93 
ImageJ/Fiji. The area with muscle tissue in each biopsy was determined using the freehand region 94 
function and the number of CD3 and FOXP3 within this area was manually counted at 20x 95 
magnification. 96 
 97 
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Proteomics 98 
Homogenization of tissue biopsies  99 
Approximately 1mm3 was cut from the frozen tendon and muscle biopsies and was homogenized by 100 
bead beating using ss 0.9-2.0mm beads (Bullet blender Gold, Next Advance Inc, USA) in reducing 101 
lysis buffer (5% sodium deoxycholate (SDC; Sigma Aldrich, USA), protease inhibitors (cOmplete, 102 
Roche) in 50mM TEAB (Sigma Aldrich). Protein concentration in lysates was determined by 103 
protein A280 and lysates stored at -80ºC (DeNoviX, USA).  104 
Samples were further processed using an optimized SDC filter-aided sample preparation protein 105 
digestion (SDC-FASP) essentially as 4 using 100µg protein starting material in 10kDa molecu ar 106 
weight cutoff spin-filters (Merch Millipore, Singapore). The lysates were reduced (10mM TCEP) 107 
and alkylated (50mM Chloroacetamide) each for 15min in digestion buffer (5% SDC in 50mM 108 
TEAB; Sigma-Aldrich). Overnight trypsin digestion at 37°C was performed by addition of 200μl 109 
0.5% digestion buffer containing Trypsin 1:50 (v:v; Pierce, USA). Peptides were extracted by 110 
acidification and phase-separation, where 3:1 (v/v) ethyl acetate of sample volume was added and 111 
acidified by adding Trifluoroacetic acid (Sigma-Aldrich) to a final concentration of 1% (pH<2) 112 
followed by centrifigation. The collected lower aqueo s phase containing the peptides was dried in 113 
a vacuum centrifuge and dissolved in 0.1M TEAB. Peptid  concentration in lysates was determined 114 
by protein A280 and lysates stored at -80ºC (DeNoviX, USA).  115 
iTRAQ labeling 116 
 A total of 5µg of each sample was labeled with a 4-plex iTRAQ kit (AB Sciex, USA) according to 117 
manufacturer’s instructions. Briefly, samples were re-dissolved to total volume of 25µL 0.1M 118 
TEAB, pH 8.5 while 290µL 96% ethanol were added to iTRAQ reagents. Next, 50µL of the 119 
iTRAQ reagents was transferred to the samples, which were then labelled, mixed after 1h of 120 
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incubation at room temperature dried, and resuspended in 2% acetonitrile (AcN), 0.1% TFA 121 
(Sigma-Aldrich).  122 
iTRAQ sample analysis 123 
Samples were analyzed per UPLC-TandemMS in technical duplicates. Labeled peptides were 124 
separated by a nanoUPLC system (Thermo Scientific, USA) coupled online to a Q Exactive HF MS 125 
(Thermo Scientific) using a reverse phase C18 trapping column setup with 75cm main column 126 
(Thermo Scientific) with loading in 2% solvent B (0.1% FA in AcN)  gradient and separated by 127 
176min gradient from 11%B to 30%B with a constant flow rate at 250nL/min. MS was operated in 128 
positive mode using Top10 data-dependent acquisition (MS1 m/z 375-1,500 at R 120,000) and 129 
tandems sequencing using fixed m/z range at 110 and a MS2 resolution of 15,000. 130 
Database searches 131 
Raw data were processed using Proteome Discoverer v2.3.0.523 (Thermo Scientific). Sequest HT 132 
was set as the search engine against the reviewed Uniprot Homo sapiens reference protein database 133 
(09/2017). iTRAQ 4-plex labeling of N-terminal and lysine and carbamidomethylation (C) were set 134 
as fixed modifications while oxidation (M), deamidation (N/Q) and protein N-terminal acetylation 135 
were included as variable modifications. Precursor mass tolerance and fragment mass tolerance 136 
were set at 10ppm and 0.05Da, respectively. PSMs were filtered using percolator with a strict false 137 
discovery rate (FDR) of 1% and a relaxed FDR of 5%. Unique and razor peptides were used for 138 
quantification, and iTRAQ channels were normalized to total peptide amount. Master proteins were 139 
filtered for high protein FDR confidence. MS data have been deposited to the ProteomeXchange 140 
Consortium via the PRIDE 39 partner repository with the dataset identifier PXD014037. 141 
Bioinformatics analyses and functional annotation of regulated proteins 142 
Normalized abundances were used for further analyses of proteins identified with two or more 143 
unique peptides. Data distribution was assessed with Perseus v.1.5.3.2 software and differentially 144 
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regulated features were selected using t-test with a post-hoc background-based adjusted p-145 
value<0.05 35. Venny 2.1 (http://bioinfogp.cnb.csic.es/tools/venny) was used to compare the 146 
regulated proteins among the different comparisons. ToppGene Suite8 was used for functional 147 
enrichment of regulated proteins according to Gene O tology (GO) terms and pathway analysis. 148 
Enriched lists were further accessed by String app on Cytoscape v3.6.1 44.  149 
 150 
Reverse transcription quantitative PCR (RT-qPCR) analysis of FOXP3, MYOG,  and MMP13  151 
in SS and deltoid muscle tissue 152 
RNA extraction   153 
Muscle biopsies (n=18/group) were isolated using TRIzol® Reagent. Phase separation was 154 
performed using chloroform and isopropyl alcohol was used to precipitate RNA. The RNA 155 
concentrations and purities were determined using a Nanodrop Spectrophotometer (Thermo 156 
Scientific).  157 
cDNA synthesis  158 
RNA samples were diluted to obtain a concentration of 250ng/µL, and reverse transcription was 159 
performed using an Applied Biosystem kit according to the manufacturer’s instructions. The 160 
synthesis was performed using an MJ Research PTC-225 Gradient Thermal Cycler (Marshall 161 
Scientific). cDNA samples were diluted to lower theconcentrations to ~50ng/L. 162 
RT-qPCR 163 
RT-qPCR was performed using a CFX Connect Real-Time PCR Detection System (Bio-Rad) and 164 
analyzed using SYBR green. Samples were run against standard curves generated from serial 165 
dilutions from a pool of all samples. Values were normalized to ACTB (-actin) as the reference 166 
gene and calibrated to a pool of cDNA obtained from one pectoralis and one subscapularis muscle 167 
biopsy. Triplicates of all samples, standards, and negative controls were conducted. To ensure no 168 
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sign of primer dimer formation or contamination, a no amplification control (NAC), a no template 169 
control (NTC), and a no reverse transcriptase (NRT) were included as controls.  170 
RT-qPCR cycling conditions were as follows: 10min at 95℃, followed by 40 cycles of denaturing 171 
at 95℃ for 15 seconds, 30 seconds at annealing temperatur, nd extension at 72℃ at 30 seconds. 172 
Primer sequences were: ACTB, sense 5´-GGCCACGGCTGCTTC-3´ and anti-sense 5´-173 
GTTGGCGTACAGGTCTTTGC-3´ (Ta 52℃ and Tm 84℃), FOXP3, sense 5´-174 
CCCGGATGTGAGAAGGTCTT-3´ and anti-sense 5´-TTCTCCTTCTCCAGCACCAG-3´ (Ta 175 
57℃ and Tm 82℃), MYOG, sense 5´-GCCCTGATGCTAGGAAGCC–3´ and anti-sense 5´-176 
CTGAATGAGGGCGTCCAGTC-3´ (Ta 70℃ and Tm 85℃), and MMP13, sense 5´-CGC CAG 177 
ACA AAT GTG ACC CT-3´ and anti-sense 5´-CAG GCG CCA G A GAA TCT GT-3´ (Ta 55℃ 178 
and Tm 77℃). Primer specificity was ensured by generation and evaluation of melting curves. 179 
Primers were purchased from TAG Copenhagen. 180 
 181 
Electrochemiluminescence analysis 182 
Protein purification 183 
Tendon and muscle samples were homogenized at 4°C in Mesoscale Lysis buffer containing 184 
Phosphatase Inhibitor Cocktail 2 and 3 (Sigma-Aldrich) and Complete Mini EDTA-free Protease 185 
Inhibitor (Roche). Protein content was measured by the bicinchoninic acid method using the 186 
Thermo Scientific Micro BCATM Protein assay Kit (Pierce Chemical Co) 40. 187 
Multiplex analysis 188 
Protein concentrations in tendon and muscle samples were measured using an MSD human U-Plex 189 
Biomarker Multip-Plex Kit, a U-PLEX human TGF-β Combo Kit, a human MMP 3-Plex Ultra-190 
Sensitive Kit, and human TNF-RI and TNF-RII Ultra-Sensitive Kits (all from Mesoscale), using the 191 
MSD QuickPlex (SQ120) Plate Reader (Mesoscale) according to the manufacturer’s instructions. 192 
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ICAM-1 and VCAM-1 analyses were performed on SS and deltoid muscle tissue using V-PLEX 193 
Vascular Injury Panel 2 (Mesoscale). Samples were run in duplex and diluted 2- or 4-fold in Diluent 194 
41 prior to measurement. Data were analyzed using MSD Discovery Workbench software. The 195 
lower limit of detection was a calculated concentration based on a signal 2.5 standard deviations 196 
(SD) above the blank (zero) calibrator and coefficient of variation (CV) values below 25% were 197 
accepted. 198 
 199 
Statistical analysis 200 
To examine differences in protein expression between SS and deltoid muscle tissue, paired 201 
Student’s t-test was used. Correlation analyses between cytokine, MMPs, and growth factors versus 202 
age of lesion used Spearman’s test.To examine the corr lation between the relative expression of 203 
FOXP3, MYOG, and MMP13 in SS and deltoid muscles, a paired Wilcoxon test was carried out. 204 
The outlier test ROUT was used to identify and remove utliers more than 2 SD from the dataset. 205 
All statistical analyses were carried out using GraphPad Prism. P-values ≤0.05 were considered 206 
statistically significant. Data are presented as mean±SD or median (25, 75 interquartile range,  207 
IQR). 208 
 209 
Results 210 
Mass spectrometry-based proteomics analysis shows protein regulation upon RC lesion 211 
Using quantitative mass spectrometry (MS) proteomics, a total of 2,463 proteins were identified, of 212 
which 1,895 had two or more unique peptides (Supplementary Table S2). Moreover, 417 quantified 213 
proteins were shared by all tissues of all patients a d could be assessed by principal component 214 
analysis (PCA) (Supplementary Figure 1A), which showed a clear distribution pattern  even in the 215 
absence of well-delimited clusters. 216 
Jo
urn
al 
Pr
e-p
r o
f
10 
 
To better understand protein regulation underlying RC pathology, SS muscle protein expression 217 
pattern was compared to deltoid as a non-RC shoulder muscle control. A total of 239 proteins were 218 
regulated. Of these, 114 were more highly expressed in the SS muscle (Figure 2A, Supplementary 219 
Table S3). Gene ontology analysis showed ‘extracellular matrix organization’ and ‘neutrophil 220 
degranulation’ among the most enriched biological processes (Supplemental Figure 2,  Table S4) 221 
while ‘degradation of extracellular matrix’, ‘innate immune system’ and ‘neutrophil degranulation’ 222 
were among the enriched pathways of upregulated proteins (Figure 2B, Supplementary Figure 2, 223 
and Supplementary Table S4). Interestingly, ‘mitochondrial cellular localization’, and ‘muscle 224 
system process’ were among the enriched annotations of downregulated proteins (Figure 2B, 225 
Supplementary Figure 3, and Table S4). A detailed lst of regulated proteins involved in the above-226 
mentioned processes, along with experimental ratio, re provided in Figure 2C-K. 227 
To address the molecular response of different RC tissues, the comparison between SS muscle and 228 
SS tendon showed 139 differentially expressed proteins (Supplementary Table S5). Pathways or 229 
gene ontologies related to immune response or inflamm tory processes were not enriched among 230 
these regulated proteins.  231 
In contrast, pointing towards a common molecular signature between SS muscle and SS tendon in 232 
RC disease, 38 proteins were regulated in both tissues when compared to deltoid muscle 233 
(Supplementary Figure 1B, Supplementary Tables S6 and S7). Several of these proteins were 234 
related to catalytic activity, with mitochondrial protein complex being the main cellular component 235 
(Supplementary Figure 1C). 236 
 237 
RC lesion results in atrophy and lipid accumulation 238 
Staining with hematoxylin & eosin revealed muscle fib r changes already 1½ months after tendon 239 
lesion represented by internalization of nuclei andmuscle fibers of varying size after the tendon tear240 
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(Figure 3A). In addition, pathological infiltrating adipocytes were detected, as substantial fat 241 
infiltration was seen together with arrays of intracellular myonuclei and varying fiber size, 242 
suggestive of degeneration (Figure 3B,C).  243 
Inflammatory changes appeared to be intensified from 1½ months to 6 months with abundant 244 
stromal inflammatory phagocytic cells represented by the presence of CD68+ macrophages (Figure 245 
3D and 3E). At 24 months, degeneration was clearly seen with a substantial proportion of muscle 246 
cells replaced by fat cells indicative of muscle cell d generation (Figure 3F). At 24 months, absent 247 
or few CD68+ positive cells indicated decreased inflammation. The deltoid muscle did not 248 
demonstrate similar inflammatory and degenerative changes (Figure 3G-L).  249 
Adipophilin/perilipin-2 immunohistochemistry for detection of lipids in myofibers demonstrated 250 
that adipophilin was localized to the surface of intra-cellular lipid droplets (Figure 4). The 251 
expression varied both between patients (please compare Figure 4A and Figure 4C) and between 252 
muscles from the same patient (please compare Figure 4A with Figure 4B). Regional differences 253 
within muscles were also seen (Figure 4), and some individual fibers presented increased lipid 254 
accumulation both as number and size of droplets. 255 
 256 
RC tendon tear leads to changes in inflammatory mediators in SS muscle 257 
None of the patients showed any signs of peripheral infl mmation as mean blood leukocyte counts, 258 
hemoglobin, and C-reactive protein values were within normal ranges and all patients were negative 259 
for rheumatic factors. Given the findings of significant changes in the proteome of SS compared to 260 
deltoid muscle after RC tear, we investigated changes in a variety of pro- and anti-inflammatory 261 
cytokines, chemokines, receptors, and growth factors (Figure 5 and Table 1). We found lower 262 
CCL19 levels (Figure 5A) but higher CXCL5 levels (Figure 5B) in the SS compared to the deltoid 263 
muscle. IL-1β (Figure 5C), IL-6 (Figure 5D),  IL-8 (Figure 5E), and IL-33 levels (Figure 5F) were 264 
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higher in SS compared to deltoid muscle. IL-7 levels (Figure 5G), IL-15 (Figure 5H), IL-17A 265 
(Figure 5I), and IFN-α2a levels (Figure 5J) were in SS compared to deltoid muscle. Despite 266 
comparable levels of TNF (Figure 5K), TNFR1 (Figure 5L) and TNFR2 (Figure 5M) levels were 267 
changed in the SS muscle compared to the deltoid after RC tendon tear. G-CSF levels were lower in 268 
SS muscle compared to the deltoid (Figure 5N).  269 
We observed no significant correlation between age of l sion and CCL19 (r=-0.05, p=1), CXCL5 270 
(r=-0.26, p=0.31) , IL-1β (r=-0.30, p=0.3) , IL-6 (r=-0.48, p=0.07) ,IL-8 (r=-0.43, p=0.11) , IL-33 271 
(r=0.16, p=0.54) , IL-7  (r=0.35, p=0.39), IL-15  (r=0.07, p=0.79), IL-17A  (r=0.09, p=0.76), IFN-272 
α2a (r=0.39, p=0.3), TNF (r=-0.39, p=0.15) , TNFR1  (r=-0.4, p=0.29), TNFR2  (r=-0.16, p=0.66), 273 
or G-CSF  (r=0.16, p=0.71).  274 
Finally, several cytokine levels were similar in SSand deltoid muscle (Table 1). The concentration 275 
of most cytokines, chemokines, growth factors, and MMPs was high in the SS tendon 276 
(Supplementary Table 8).    277 
 278 
The regenerative potential appears to be impaired in the SS muscle after RC tendon tear 279 
IL-17 production characterizes pro-inflammatory T helper 17 lymphocytes (Th17) and innate 280 
immune cells 11. Th17 has been shown to have opposing effects in the immune response from 281 
regulatory T cells (Treg) 49, which is important in muscle regeneration (reviewed in 7) and whose 282 
master gene is the transcription factor Forkhead box P3 (FOXP3). We found decreased IL-17A 283 
levels in SS muscle compared to deltoid muscle (Figure 5G).  Therefore, we next investigated 284 
FOXP3 mRNA expression and found that FOXP3 mRNA levels were significantly lower in SS 285 
muscle compared to deltoid muscle (Figure 6A). However, when we counted FOXP3+ cells (Figure 286 
6B) and CD3+ T cells (Figure 6C) in SS and deltoid muscle tissue ections (Figure 6D), we did not 287 
observe any significant differences in the number of FOXP3+ cells/mm2 or CD3+ T cells/mm2. 288 
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Approximately 7.5% of all T cells in the SS muscle w re FOXP3+ Treg cells (overlay in Figure 6D, 289 
upper panel), and approximately 13% of all T cells in the deltoid muscle were FOXP3+ Treg cells 290 
(overlay in Figure 6D, middle panel). The number of T cells/mm2 were, however, quite variable 291 
(Figure 6D). 292 
To investigate gene expression levels involved in myogenesis, we estimated MYOG expression and 293 
found the relative mRNA levels to be significantly decreased in the SS compared to the deltoid 294 
muscle (Figure 6E). 295 
 296 
Changes in matrix metalloproteinases and transforming growth factors after RC tendon tear 297 
As gene ontology analysis showed changes in proteins involved in ‘extracellular matrix 298 
organization’, we investigated changes in the levels of 4 matrix metalloproteinases (MMPs) known 299 
to be involved in the degradation of the extracellular matrix 38.  300 
We did not observe any differences in MMP1 levels btween SS and deltoid muscle (Figure 7A). 301 
However, levels of MMP3 (that is known to degrade collagen types II-IV, IX, and X and to have 302 
important regulatory functions such as activation of other MMPs) were significantly higher in SS 303 
compared to deltoid muscle (Figure 7B). Furthermore, levels of MMP-9 (known to degrade 304 
collagen fragments IV and V) were changed (Figure 7C) suggesting decreased MMP-9 levels in 305 
deltoid compared to SS muscle. 306 
MMP13 (known to degrade primarily collagen fragments II) mRNA gene expression was absent in 307 
SS (0.005 ± 0.006, n=12) and deltoid (0.002 ± 0.002, n=16) muscle tissue, whereas MMP13 mRNA 308 
gene expression was present in SS tendon tissue (4.95 ± 5.33, n=4) in RC tear conditions.   309 
A significant negative correlation was found between age of lesion and MMP9 levels (r=-0.61, 310 
p=0.03). We found no significant correlation between age of lesion and MMP1 levels (r=0.05, 311 
p=0.87) and a tendency of a correlation with MMP3 leve s ((r=-0.46, p=0.08).  312 
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In line with previous findings in the SS enthesis (reviewed in 22), we found that protein levels of 313 
MMP-1 (known to specifically break down most subtypes of collagen,  providing mechanical 314 
strength to tissues) were higher in SS tendon than in muscle tissue (Supplementary Table 8). Also, 315 
MMP-3 was high in the SS tendon (Supplementary Table 8).  316 
We also investigated changes in transforming growth factors (TGF), known to be affected in SS 317 
enthesis following RC tear (reviewed in 22) (Figure 7D-F). Levels of TGFβ1 (Figure 7D) and 318 
TGFβ3 (Figure 7F) were higher in SS muscle, suggesting increased TGFβ1 and TGFβ3 levels in SS 319 
muscle compared to deltoid muscle. We found no correlation between age of lesion and TGFβ1 320 
(r=0.12, p=0.7), TGFβ2 (r=-0.07, p=0.83), or TGFβ3 (r=-0.32, p=0.34). 321 
 322 
Discussion 323 
In this study, we demonstrated massive SS muscle inflammation after tendon tear combined with 324 
fatty infiltration and degeneration. Simultaneous changes in the innate immune response, cytokines, 325 
and proteins related to extracellular matrix reorganiz tion and mediation of fibrosis in the SS 326 
musculature were also seen.  327 
In line with previous experimental studies using mice 28 and rats 12; 17; 18 we observed high numbers 328 
of infiltrating monocytes/macrophages in SS muscle in arly cases of tendon tear; this tendency 329 
ceased after 24 months, however. Inflammation was (initially) driven by high numbers of 330 
infiltrating CD68+ macrophages, which are thought to be key sources of TGF-β1 linked to fibrosis 331 
in chronically injured muscle 30.  332 
Upregulated proteins in SS muscle compared to deltoi  also showed ‘neutrophil degranulation’ 333 
among the most enriched processes. Neutrophils have been identified as the main cells infiltrating 334 
the muscle after injury 46, and neutrophil-derived oxidants extended tissue damage in a rabbit model 335 
of stretch skeletal muscle injury 47. On the other hand, blocking cell infiltration compromised the 336 
initial regenerative response, suggesting a role for neutrophils in muscle growth and repair by 337 
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removal of tissue debris and activation of satellite cells 47.  Moreover, a recent study has shown that 338 
neutrophil-secreted proteases can also have an immunoregulatory role by activating IL-33 9. IL-33 339 
has been shown to be produced by fibro-adipogenic progenitor (FAP) cells, which are uniformly 340 
present in the interstitial space in skeletal muscle and respond to muscle damage 20.  Our 341 
observation of higher IL-33 levels in SS muscle compared to deltoid muscle indicate an activation 342 
of FAPs, which are the source of adipocytes in muscle fatty infiltration. Muscle Foxp3+ regulatory 343 
T cells (Tregs) are characterized by high levels of expression of the IL-33 receptor, ST2, and are 344 
known to potentiate regeneration in acute and chronic injury models 7. Despite comparable numbers 345 
of Foxp3+ Tregs/mm2, we saw a significant decrease in FOXP3 mRNA levels in SS muscle 346 
compared to deltoid muscle following RC tear, suggestiv  of repressed gene expression in Tregs 347 
located in SS muscle. Many cytokines and factors can negatively regulate FOXP3 gene expression, 348 
including IL-6, IL-7, TGF-β, and G-CSF, 21; 32; 42, all of which we observed to be different between 349 
SS and deltoid muscle.  350 
The expression of IL-15 has been shown to inhibit fatty infiltration and facilitate muscle 351 
regeneration through regulation of FAP cells 23.  In the present study, IL-15 levels were 352 
significantly lower in the SS compared to the deltoid muscle, supporting our findings that 353 
adipocytes appear in the SS and that the regenerativ  potential appears to be reduced in SS muscle 354 
after RC tendon tear. 355 
IL-17 is a pro-inflammatory cytokine secreted by activated CD4+ T-helper cells (Th17), which are 356 
highly pro-inflammatory and induce severe autoimmunity (reviewed in 27). IL-17 levels are 357 
increased in early human tendinopathy, mediating inflammatory and tissue remodeling events 34, 358 
and  IL-17 inhibits myoblast differentiation 26. In the present study, IL-17 levels were significantly 359 
lower in SS than in deltoid muscle, but the exact relevance of decreased IL-17 levels remains to be 360 
elucidated. 361 
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Our gene ontology analysis showed changes in ‘extracellular matrix organization’ and ‘degradation 362 
of extracellular matrix’ especially due to the upregulation of CMA1, COL5A3, CTSS, ELN, and 363 
MMP19 in SS compared to deltoid muscle. To our knowledge, no one has investigated MMP levels 364 
in human SS muscle under tear conditions. MMPs are a large group or proteolytic enzymes 365 
responsible for tissue remodeling and degradation of extracellular matrix. In our study, MMP-3 and 366 
MMP-9 levels were significantly increased in SS compared to deltoid muscle. MMP-3 is one of the 367 
primary activators of MMP-9 from its inactive proenzyme form 36. MMP-9 is produced by a variety 368 
of cells, including fibroblasts. MMP-9 appears to be a regulatory factor in neutrophil migration 369 
across the basement membrane 13, and it also plays several important functions within neutrophil 370 
action 27 such as degrading extracellular matrix, activation of IL-1β, and cleavage of several 371 
chemokines 37. In vitro studies have demonstrated that inhibition of MMP-9 reduced the levels of 372 
active TGF-β1 and reduced several TGF-β1 driven responses such as fibroblast stimulation 25. In 373 
this context, MMP-9 appears to activate or stimulate the release of a number of cytokines and 374 
growth factors, including TGF-β1 31, which we found to be elevated in SS compared to deltoi  375 
muscle. MMP-9 activity positively correlated to skeletal muscle atrophy in immobilized rats 41, 376 
supporting a role in muscle atrophy. This is in line with our present findings of a positive 377 
correlation between MMP-9 levels and age of RC lesion. Altogether, this suggests that MMP-9 378 
plays an important role in SS muscle remodeling.  379 
While only a few studies have applied a large-scale proteomics approach to address RC 380 
pathophysiology, these studies combined found several markers indicative of tissue remodeling and 381 
suggested an untapped potential for proteomics in tendon research (reviewed in 43). A multi-omics 382 
methodology applied to a rat RC injury model to study myosteatosis identified disrupted 383 
mitochondrial function as one of the underlying mechanisms of lipid accumulation in muscle fibers 384 
19. In our study, we identified 32 downregulated mitoch ndrial proteins, 15 of which are associated 385 
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with mitochondrial electron transport chain. Mitochndrial dysfunction reduces energy production 386 
and the dysfunction of these organelles has been con e ted to the myosteatosis that is commonly 387 
reported following RC tendon injury 3. Our finding of steatotic adipophilin positive muscle fibers 388 
and changes in lipid metabolism and mitochondrial function supports this connection. 389 
 390 
This study has certain inherent limitations related to the variability of disease severity and duration 391 
and the sample size, and the results are biased towards patients with RC tears who chose to undergo 392 
surgery. The enrolled patients comprised four smokers and seven patients who received pain killers 393 
on a daily basis. The adverse consequences of smoking and mild anti-inflammatory drug intake on 394 
the inflammatory response was not assessed due to lack of statistical power. Another limitation 395 
inherent in muscle biopsy studies is the difficulty of ensuring uniform biopsy procedures, which  396 
are important to secure reproducibility and to account for regional variations in protein 397 
composition. In this study, biopsies were obtained close to the musculotendinous junction of the SS 398 
muscle in all patients using an all-arthroscopic approach from the bursal side, limiting possible 399 
location-dependent variations.  400 
The rationale for using the deltoid muscle for comparison could be challenged as it may be 401 
asymptomatically affected. The ipsilateral deltoid has been used as a standard of reference in a 402 
number of studies 2; 13,  also justifying the use of paired statistics andincreasing the power of the 403 
analyses. 404 
 405 
Conclusions 406 
This study demonstrated massive muscle changes after SS tendon tear characterized by high 407 
numbers of inflammatory macrophages in lesions less than three months old and overall changes in 408 
cytokine levels, MMP levels, and growth factors. Our proteome analysis demonstrated that proteins 409 
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involved in inflammation, extracellular matrix reorganization, and lipid metabolism were among the 410 
most enriched. Knowing that massive inflammation with infiltration of immune cells into the RC 411 
musculotendinous lesion disrupt normal muscle regenration, this implies that intervention with 412 
repair of the tendon lesion and concomitant target-sp cific adjuvant treatment of the inflammatory 413 
state of the SS muscle could be key to improving RC muscle recovery.  414 
 415 
Figure legends 416 
 417 
Figure 1. Schematic workflow applied to the study of molecular pathways involved in the RC 418 
lesion. Biopsies of supraspinatus tendon and supraspinatus and deltoid muscle biopsies from ten 419 
patients undergoing surgery for partial or full-thickness RC were evaluated. 420 
 421 
Figure 2. Proteomics of muscle biopsies. (A) Differentially regulated protein pattern between SS 422 
and deltoid muscles from patients with RC lesion (FDR 5%). Downregulated proteins are 423 
represented in blue and upregulated in red. Dotted lin s highlight proteins at least 2 times 424 
overrepresented in each tissue. (B) Protein-protein n twork of SS vs deltoid muscle-regulated 425 
proteins grouped according functional enrichment. Uderrepresented proteins in SS muscle are 426 
shown in blue while overrepresented are shown in red. (C-K) Levels of upregulated (red) or 427 
downregulated (blue) proteins involved in Leukocyte m diated immunity (C), Immune effector 428 
process (D), Immune system (E), Positive regulation of lipid metabolic processes (F), Metabolism 429 
of lipids (G), Electron transport chain (H), Muscle structure development (J), Extracellular matrix 430 
organization (I), and Striated muscle contraction (K) as measured by proteomics (n=10 muscles per 431 
group). Abbreviations: ADAR, double-stranded RNA-specific adenosine deaminase; ADIPOQ, 432 
adiponectin; ALDH5A1, succinate-semialdehyde dehydrogenase, mitochondrial; ANKRD1, 433 
ankyrin repeat domain-containing protein 1; ANKRD2, ankyrin repeat domain-containing protein 2; 434 
AP1B1, AP-complex subunit beta-1; APOA1, apolipoprotein A-1; APOA2, apolipoprotein A-2; 435 
APOA4, apolipoprotein A-4; APOE, apolipoprotein E; CMA1, chymase; COL5A3, collagen alpha-436 
3(V) chain; COX6A1, cytochrome c oxidase subunit 6A1; COX6A2,  cytochrome c oxidase subunit 437 
6A2; COX6B1, cytochrome c oxidase subunit 6B1; CTSA, cathepsin A; CTSC, cathepsin C; CTSS, 438 
cathepsin S; DNM1, dynamin-1; DNM2, dynamin-2; EEF1A2, elongation factor-1 alpha; ELN, 439 
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elastin; ENG, endoglin; F2, prothrombin; FABP4, fatty acid-binding protin; FASN, fatty acid 440 
synthase; FBN1, fibrillin-1; FDXR, NADPH:adrenodoxin oxidoreductase, mitochondrial; FITM2, 441 
fat storage-inducing transmembrane protein 2; GGH, gamma-glutamyl hydrolase; GLRX5, 442 
glutaredoxin-related protein 5, mitochondrial; GNS, N-acetylglucosamine-6-sulfatase; GSR, 443 
glutathione reductase, mitochondrial; HEXA, beta-hexosaminidase subunit alpha; HLA-A, HLA 444 
class I histocompatibility antigen, A-31 alpha chain; HPGDS, hematopoietic prostaglandin D 445 
synthase; HUWE1, E3 ubiquitin-protein ligase; ICAM1, intercellular adhesion molecule 2; 446 
LGALS1, galectin-1; MFAP4, microfibril-associated glycoprotein 4; MMP19, matrix 447 
metalloproteinase-19; MYH3, myosin-3; MYH7, myosin-7; MYL2, myosin light chain 2; MYL3, 448 
myosin light chain 3; MYL6B, myosin light chain 6B; MYOZ2, myozenin-2; ND4, NADH-449 
ubiquinone oxidoreductase chain 4; NDUFA4, cytochrome c oxidase subunit NDFUA4; NDUFA9, 450 
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial; NDUFAB1, 451 
acyl carrier protein, mitochondrial; NDUFB3, NADH dehydrogenase [ubiquinone] 1 beta 452 
subcomplex subunit 3; NDUFC2, NADH dehydrogenase [ubiquinone] 1 subunit C2; NDUFS5, 453 
NADH dehydrogenase [ubiquinone] iron-sulfur protein 5; NDUFS7, NADH dehydrogenase 454 
[ubiquinone] iron-sulfur protein 7, mitochondrial; NUP62, nuclear pore glycoprotein p62; OSTF1, 455 
osteoclast-stimulating factor 1; PLIN1, perilipin-1; PON2, serum paraoxonase/arylesterase 2; PPT1, 456 
palmitoyl-protein thioesterase 1; PRDX4, peroxiredoxin-4; PTPRC, receptor-type tyrosine-protein 457 
phosphatase C; PYCARD, apoptosis-associated speck-like protein containing a CARD; SACM1L, 458 
phosphatidylinositide phosphatase SAC1; SERPINB12, serpin B12; SLC25A1, tricarboxylate 459 
transport protein, mitochondrial; SNRPA1, U2 small nuclear ribonucleoprotein A; SORBS1, sorbin 460 
and SH3 domain-containing protein 1; TNNI1, troponin I, slow skeletal muscle; TNNT1, troponin 461 
T, slow skeletal muscle; UCHL1, ubiquitinin carboxyl-terminal hydrolase isozyme L1; UQCR11, 462 
cytochrome b-c1 complex subunit 10; VCAM1, vascular cell adhesion protein 1.   463 
 464 
Figure 3. Histological analysis of SS muscle. (A-C) H&E-stained tissue sections of SS muscle 465 
biopsies from representative patients at 1½ months (A), 6 months (B), and 28 months (C) after RC 466 
tendon tear demonstrating the presence of muscle fibers with internal nuclei (arrows) and nuclear 467 
chains (arrow heads). (D-F) Immunohistochemical staining of SS muscle biopsies from 468 
representative patients at 2½ months (D), 6 months (E), and 28 months (F) demonstrating the 469 
presence of a high number of CD68+ macrophages (arrows) within the first 6 months after RC 470 
tendon tear. Please note the presence of massive fatty cell infiltration (*, asterisks) between muscle 471 
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fibers already early after RC tendon tear. (G-I) H&E-stained tissue sections of deltoid biopsies from 472 
representative patients at 1½ months (G), 6 months (H), and 24 months (I) after RC tendon tear. (J-473 
L) CD68 immunohistochemical staining of deltoid muscle biopsies biopsies from representative 474 
patients at 1½ months (J), 6 months (K), and 24 months (L) after RC tendon tear. Scale bar: 100µm. 475 
 476 
Figure 4. Immunohistochemical staining for adipophilin. (A,B) Adipophilin expression in SS 477 
(A) and deltoid (B) muscle fibers in a patient with a 6-month-old RC lesion, showing higher 478 
adipophilin expression in the SS muscle compared to the deltoid. Adipophilin is seen as a granular 479 
staining in the muscle fiber cytoplasm and due to its localization to the surface of lipid vacuoles, it 480 
visualizes the distribution one of intracellular lipid. (C,D) Adipophilin expression in SS and deltoid 481 
muscle fibers from patient with a >72-month-old RC tear (C) and another patient with a 7-month-482 
old RC lesion (D). Please note that the distribution of adipophilin can be uneven with different 483 
expression in neighboring fascicles in both the SS and deltoid muscles. Scale bar: 100µm.    484 
 485 
Figure 5. Cytokine and TNF receptor protein expression in SS and deltoid muscle tissue in 486 
RC tear conditions. (A-N) Electrochemiluminescence immunoassay analysis of CCL19 (A), 487 
CXCL5 (B), IL-1β (C), IL-6 (D), IL-8 (E), IL-33 (F), IL-7 (G), IL-15 (H), IL-17A (I), INF-α2a (J), 488 
TNF (K), TNFR1 (L), TNFR2 (M), and G-CSG (N) protein levels in SS and deltoid muscle 489 
biopsies from patients with RC tendon tear. ***p<0.0 1, **p<0.01. *p<0.05, Student’s t-test (n = 490 
22/group). Samples with CV values above 25% were excluded in individual analyses. 491 
 492 
Figure 6.  FOXP3 and MYOG mRNA expression is lower in SS muscle than in deltoid muscle 493 
tissue in RC tear conditions. (A) FOXP3 mRNA levels in SS and deltoid muscle biopsies 494 
demonstrated significantly lower expression levels in SS compared to deltoid muscle. **p<0.01, 495 
paired Student’s t-test (n=18/group). Two outliers in the SS muscle and two outliers in the deltoid 496 
muscle group were removed according to ROUT’s outlier est. (B-C) The number of FOXP3+ Treg 497 
cells/mm2 (B) and the total number of CD3+ T cells (C) were comparable between SS and deltoid 498 
muscle in RC tear conditions. (D) Representative FOXP3 and CD3 immunohistochemically stained 499 
tissue sections from SS and deltoid muscle demonstrating overlay between subsets of FOXP3+ and 500 
CD3+ T cells, representing the presence of Treg cells (arrows) in both SS and deltoid muscle in RC 501 
tear conditions. Scale bars: 50µm (top and middle panels) and 100µm (bottom panel). (E) MYOG 502 
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mRNA levels in SS and deltoid muscle biopsies demonstrated significantly lower expression levels 503 
in SS compared to deltoid muscle. **p<0.01, paired Student’s t-test (n=18/group). 504 
 505 
Figure 7. Matrix metalloprotease and transforming growth factor-β protein expression in SS 506 
and deltoid muscle tissue under RC tear conditions. (A-F) Electrochemiluminescence 507 
immunoassay analysis of MMP-1 (A), MMP-3 (B), MMP-9 (C), TGFβ1 (D), TGFβ2 (E), and 508 
TGFβ3 (F) protein levels in SS and deltoid muscle biopsies from patients with RC tendon tear. 509 
*p<0.05, Student’s test (n = 22/group). Samples with CV values above 25% were excluded in 510 
individual analyses. 511 
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Table 1. Cytokine analysis in patients with RC tear. 
 SS muscle (pg/mg) Deltoid muscle (pg/mg) P-value 
IL-1α 2.44 ± 1.38 (n=13) 2.21 ± 1.72 (n=15) 0.83 
IL-1Ra 46.83 ± 20.24 (n=14) 34.40 ± 12.94 (n=15) 0.33 
IL-2 0.64 ± 0.47 (n=4) 0.41 ± 0.24 (n=5) 0.50 
IL-2Ra 93.08 ± 56.28 (n=8) 99.11 ± 76.81 (n=7) 0.87 
IL-4 0.04 ± 0.07 (n=6) 0.07 ± 0.08 (n=6) 0.53 
IL-9 1.12 ± 0.72 (n=16) 1.10 ± 0.62 (n=17) 0.98 
IL-12/IL-23p40 14.35 ± 29.01 (n=15) 14.64 ± 7.71 (n=18) 0.78 
IL-12p70 0.23 ± 0.07 (n=6) 0.39 ± 0.32 (n=7) 0.55 
IL-13 2.76 ± 2.25 (n=3) 4.35 ± 3.68 (n=3) 0.31 
MIF 28,656 ± 18,419 (n=9) 26,617 ± 19,295 (n=8) 0.36 
IFN-β 46.08 ± 27.05 (n=8) 34.05 ± 37.80 (n=7) 0.56 
IFN-γ 2.23 ± 3.48 (n=5) 2.92 ± 2.11 (n=4) 0.95 
FLT3L 14.29 ± 5.13 (n=5) 15.01 ± 8.78 (n=4) 0.93 
TRAIL 54.41 ± 23.81 (n=17) 47.00 ± 17.70 (n=19) 0.50 
CXCL1/GROα 2.63 ± 2.05 (n=9) 3.92 ± 3.37 (n=8) 0.16 
CXCL10/IP-10 8.73 ± 4.00 (n=7) 8.69 ± 2.94 (n=9) 0.86 
CXCL11/I-TAC 6.74 ± 2.02 (n=15) 7.78 ± 3.00 (n=19) 0.28 
CCL2/MCP1 4.03 ± 2.38 (n=8) 4.83 ± 2.17 (n=9) 0.33 
CCL3/MIP-1 α 4.58 ± 2.35 (n=5) 4.01 ± 4.05 (n=2) - 
CCL4/MIP-1β 5.17 ± 1.62 (n=9) 6.35 ± 1.54 (n=8) 0.29 
CCL7/MCP-3 4.92 ± 2.59 (n=8) 4.03 ± 3.41 (N=6) 0.33 
CCL8/MCP-2 1.52 ± 0.76 (n=8) 1.71 ± 1.11 (n=4) 0.48 
CCL13/MCP4 15.64 ± 11.80 (n=8) 9.57 ± 7.33 (n=7) 0.24 
CCL17/TARC 3.05 ± 1.01 (n=7) 3.40 ± 0.59 (n=8) 0.41 
M-CSF 5.45 ± 3.46 (n=9) 6.27 ± 3.39 (n=6) 0.84 
GM-CSF 0.13 ± 0.14 (n=3) 0.10 ± 0.11 (n=7) 0.33 
LT-α 1.60 ± 0.79 (n=6) 1.67 ± 0.61 (n=9) 0.41 
YKL-40/CHI3L1 121.40 ± 37.64 (n=5) 340.80 ± 274.40 (n=9) 0.18 
VEGF-A 93.36 ± 31.19 (n=7) 134.40 ± 53.22 (n=9) 0.19 
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